Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ashland Inc. Common Stock (NY:ASH)

49.52 -1.86 (-3.62%)
Official Closing Price Updated: 7:00 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ashland Inc. Common Stock

< Previous 1 2 3 Next >
Ashland board authorizes quarterly dividend
From Ashland, Inc.
Via GlobeNewswire
Ashland announces executive leadership changes
From Ashland, Inc.
Via GlobeNewswire
Ashland reports second quarter fiscal 2025 results and revises full-year outlook
From Ashland, Inc.
Via GlobeNewswire
Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast
From Ashland, Inc.
Via GlobeNewswire
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China 
From Ashland, Inc.
Via GlobeNewswire
Ashland to host 2025 Innovation Day for analysts and investors
From Ashland, Inc.
Via GlobeNewswire
Ashland completes sale of Avoca business to Mane
From Ashland, Inc.
Via GlobeNewswire
Ashland reports financial results for first quarter fiscal 20251, reiterates outlook for full-year fiscal 2025
From Ashland, Inc.
Via GlobeNewswire
Ashland board authorizes quarterly dividend
From Ashland, Inc.
Via GlobeNewswire
Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast
From Ashland, Inc.
Via GlobeNewswire
Ashland signs definitive agreement to sell Avoca business to Mane
From Ashland, Inc.
Via GlobeNewswire
Ashland rings opening bell at NYSE recognizes 100-year anniversary
Company to hold investor strategy update event on December 10, 2024 
From Ashland, Inc.
Via GlobeNewswire
Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing
From Ashland, Inc.
Via GlobeNewswire
Ashland board authorizes quarterly dividend
From Ashland, Inc.
Via GlobeNewswire
Ashland to host live 2024 strategy update event for analysts and investors
From Ashland, Inc.
Via GlobeNewswire
Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event
From Ashland, Inc.
Via GlobeNewswire
Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast
From Ashland, Inc.
Via GlobeNewswire
Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals
Technology successfully validated by field trials and successful customer pilots; commercial samples and material now available 
From Ashland, Inc.
Via GlobeNewswire
Ashland completes sale of nutraceuticals business
From Ashland, Inc.
Via GlobeNewswire
Ashland board authorizes quarterly dividend
From Ashland, Inc.
Via GlobeNewswire
Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024
From Ashland, Inc.
Via GlobeNewswire
Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast
From Ashland, Inc.
Via GlobeNewswire
Ashland announces strategy, mergers and acquisitions, and portfolio management leader
From Ashland, Inc.
Via GlobeNewswire
Ashland achieves certification by Fair Wage Network
From Ashland, Inc.
Via GlobeNewswire
Ashland announces Life Sciences business leader
From Ashland, Inc.
Via GlobeNewswire
Ashland Board appoints Ashish K. Kulkarni as new director
From Ashland, Inc.
Via GlobeNewswire
Ashland board authorizes quarterly dividend
From Ashland, Inc.
Via GlobeNewswire
Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business
From Turnspire Capital Partners LLC
Via Business Wire
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
From Ashland, Inc.
Via GlobeNewswire
Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
From Ashland, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.